Developer docs
API playgroundTry for free, no card

Search company profiles

Rohto Mentholatum

Full company profile

uuid000t8ei

Namestring
Rohto Mentholatum
Websiteurl
rohto.com.vn
Company typeenum
Private
Founded yearint
1996
Descriptiontext

Rohto Mentholatum is a Hanoi-based for-profit manufacturer specializing in pharmaceuticals and health-care cosmetic products, with operations registered in Vietnam and an indicated presence in the Japanese market. The firm was established in 1996 and operates with a small workforce of 11-50 employees, consistent with a localized manufacturing, distribution, or regional brand-operations node rather than a full-scale multinational. The "Rohto Mentholatum" naming is directly associated with Japan's Rohto Pharmaceutical group and the heritage Mentholatum brand family, which spans OTC eye care, topical analgesics, and personal care categories; however, the available sources do not enumerate the entity's specific SKU portfolio, manufacturing capacity, or product technology platform.

The company's geographic footprint covers Vietnam (Hanoi) and Japan, but no specific customer segments, channel partners, distributor relationships, or end-market split are disclosed in the available sources. Revenue model, pricing structure, and contract economics are likewise not documented, and no disclosed financials are available. The firm maintains a consumer-facing web presence at rohto.com.vn, though the captured page content consisted only of a loading/verification placeholder rather than substantive product or company information.

There is no evidence in the provided data of recent funding rounds, M&A activity, leadership changes, product launches, partnerships, certifications, patents, regulatory actions, or technology stack disclosures. Ownership structure is not definitively established: while the naming strongly suggests affiliation with the Japanese Rohto group, the parent_company field returns "has_parent: false" with "unknown" parent_type, and no institutional shareholders, founder involvement, or governance details are evidenced. This represents a significant data gap for understanding the entity's strategic posture, capital structure, and group-level integration.

Short descriptiontext

Rohto Mentholatum is a Hanoi-based manufacturer of pharmaceuticals and health-care cosmetic products, operating in Vietnam and Japan with 11-50 employees under the heritage Rohto and Mentholatum brand families.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHanoi, Vietnam
HQ citystring
Hanoi
HQ countrystring
Vietnam
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
pharmaceutical manufacturing, healthcare cosmetics, eye care products, OTC medicines, personal care products
Industry2 codes
1Eye, Ear & Nasal Care
CodeHLAIADAFPrimaryYes
2Dermatology & Aesthetics Pharmaceuticals
CodeHLAIAAAKPrimaryNo
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing3254
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Perfumes, Cosmetics & Other Toilet Preparations2844
Product category
Consumer Healthcare and Personal Care Manufacturing
Cost components5 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Rohto Mentholatum manufactures and sells pharmaceuticals and health-care cosmetic products. Operating in Vietnam under the Rohto corporate brand, the company produces consumer healthcare, personal care, and ophthalmic-related items distributed through retail pharmacy and modern trade channels.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

No specific product information for Rohto Mentholatum is available in the provided source data. The news source references the broader Japan anti-aging products market encompassing skincare, supplements, haircare, and functional products, but does not enumerate Rohto Mentholatum's individual product offerings or portfolio structure. The webpage source contains only a loading/verification page with no substantive content.

Product and service2 records
1Pharmaceutical products
CategoryPharmaceuticals
2Healthcare cosmetic products
CategoryHealth-care cosmetics
Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

The Japanese parent group and global brand owner of Rohto Mentholatum. Directly comparable as the originator of the ophthalmic and OTC product portfolio that the Vietnamese subsidiary distributes and manufactures.

TypeDirect peer
Description

Japanese specialty ophthalmic pharmaceutical company with significant Asia-Pacific operations. Directly comparable in eye-care and OTC ophthalmic categories that are Rohto Mentholatum's flagship offerings.

TypeDirect peer
Description

Japanese ophthalmic pharmaceutical manufacturer with a strong OTC eye-drop portfolio. Highly comparable in formulation type, channel (pharmacy retail), and Asian market focus.

TypeDirect peer
Description

Japanese OTC pharmaceutical and personal-care company. Comparable in business model of branded OTC healthcare products, including ophthalmics, skincare, and consumer health categories.

TypeBroad incumbent
Description

Major Japanese OTC pharmaceutical manufacturer with strong Southeast Asian presence. Comparable across OTC drugs, health tonics, and consumer healthcare product lines.

TypeDirect peer
Description

Japanese household and personal-care products manufacturer with OTC and pharmaceutical offerings. Comparable in combining consumer health, oral care, and topical pharmaceutical categories.

TypeBroad incumbent
Description

OTC arm of Daiichi Sankyo, focused on consumer healthcare products including dermatology and oral care. Comparable in branded OTC positioning and Asian distribution footprint.

TypeDirect peer
Description

One of Vietnam's largest domestic pharmaceutical manufacturers. Directly comparable as a Vietnamese-headquartered pharma manufacturer competing for the same shelf space, pharmacy relationships, and consumer healthcare spend.

TypeDirect peer
Description

Major Vietnamese pharmaceutical company with a strong OTC and consumer healthcare portfolio. Comparable as a domestic competitor pursuing similar OTC pharmaceutical and health-cosmetic categories.

TypeBroad incumbent
Description

Global ophthalmic pharmaceutical and consumer eye-care company. Comparable in eye-care and OTC ophthalmic product categories where Rohto Mentholatum competes, though operating globally at far larger scale.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Rohto Mentholatum

Consumer Healthcare and Personal Care Manufacturingrohto.com.vn

Rohto Mentholatum is a Hanoi-based manufacturer of pharmaceuticals and health-care cosmetic products, operating in Vietnam and Japan with 11-50 employees under the heritage Rohto and Mentholatum brand families.

What Rohto Mentholatum does

Rohto Mentholatum is a Hanoi-based for-profit manufacturer specializing in pharmaceuticals and health-care cosmetic products, with operations registered in Vietnam and an indicated presence in the Japanese market. The firm was established in 1996 and operates with a small workforce of 11-50 employees, consistent with a localized manufacturing, distribution, or regional brand-operations node rather than a full-scale multinational. The "Rohto Mentholatum" naming is directly associated with Japan's Rohto Pharmaceutical group and the heritage Mentholatum brand family, which spans OTC eye care, topical analgesics, and personal care categories; however, the available sources do not enumerate the entity's specific SKU portfolio, manufacturing capacity, or product technology platform.

The company's geographic footprint covers Vietnam (Hanoi) and Japan, but no specific customer segments, channel partners, distributor relationships, or end-market split are disclosed in the available sources. Revenue model, pricing structure, and contract economics are likewise not documented, and no disclosed financials are available. The firm maintains a consumer-facing web presence at rohto.com.vn, though the captured page content consisted only of a loading/verification placeholder rather than substantive product or company information.

There is no evidence in the provided data of recent funding rounds, M&A activity, leadership changes, product launches, partnerships, certifications, patents, regulatory actions, or technology stack disclosures. Ownership structure is not definitively established: while the naming strongly suggests affiliation with the Japanese Rohto group, the parent_company field returns "has_parent: false" with "unknown" parent_type, and no institutional shareholders, founder involvement, or governance details are evidenced. This represents a significant data gap for understanding the entity's strategic posture, capital structure, and group-level integration.

Rohto Mentholatum firmographics

Firmographics
Name
Rohto Mentholatum
Website
https://rohto.com.vn
Company type
Private
Founded year
1996
Operating status
Operating
Headcount range
11–50 employees
Short description
Rohto Mentholatum is a Hanoi-based manufacturer of pharmaceuticals and health-care cosmetic products, operating in Vietnam and Japan with 11-50 employees under the heritage Rohto and Mentholatum brand families.
Ownership category
akta.pro rank

Rohto Mentholatum industry classification

Industry
Product category
Consumer Healthcare and Personal Care Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
SIC
Pharmaceutical Preparations (2834), Perfumes, Cosmetics & Other Toilet Preparations (2844)
akta.pro primary industry
Eye, Ear & Nasal Care (HLAIADAF)
akta.pro secondary industry
Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

Keywords

  • Pharmaceutical manufacturing
  • Healthcare cosmetics
  • Eye care products
  • OTC medicines
  • Personal care products

Where Rohto Mentholatum is headquartered

Location

Headquarters

HQ city
Hanoi
HQ country
Vietnam
HQ region
Asia

Markets served

Rohto Mentholatum business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Rohto Mentholatum product offering

Product offering

Core offering

Rohto Mentholatum manufactures and sells pharmaceuticals and health-care cosmetic products. Operating in Vietnam under the Rohto corporate brand, the company produces consumer healthcare, personal care, and ophthalmic-related items distributed through retail pharmacy and modern trade channels.

Product overview

No specific product information for Rohto Mentholatum is available in the provided source data. The news source references the broader Japan anti-aging products market encompassing skincare, supplements, haircare, and functional products, but does not enumerate Rohto Mentholatum's individual product offerings or portfolio structure. The webpage source contains only a loading/verification page with no substantive content.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pharmaceutical products
  • Healthcare cosmetic products

Companies that use Rohto Mentholatum

Customer profile

Ideal customer profiles1 record

Rohto Mentholatum technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Rohto Mentholatum partnerships and signals

Strategic signal

Recent moves2 records

Expansion highlights2 records

Rohto Mentholatum competitors and assessment

Company assessment

Broad incumbents

  • Rohto Pharmaceutical: The Japanese parent group and global brand owner of Rohto Mentholatum. Directly comparable as the originator of the ophthalmic and OTC product portfolio that the Vietnamese subsidiary distributes and manufactures.
  • Taisho Pharmaceutical: Major Japanese OTC pharmaceutical manufacturer with strong Southeast Asian presence. Comparable across OTC drugs, health tonics, and consumer healthcare product lines.
  • Daiichi Sankyo Healthcare: OTC arm of Daiichi Sankyo, focused on consumer healthcare products including dermatology and oral care. Comparable in branded OTC positioning and Asian distribution footprint.
  • Bausch + Lomb: Global ophthalmic pharmaceutical and consumer eye-care company. Comparable in eye-care and OTC ophthalmic product categories where Rohto Mentholatum competes, though operating globally at far larger scale.

Direct peers

  • Santen Pharmaceutical: Japanese specialty ophthalmic pharmaceutical company with significant Asia-Pacific operations. Directly comparable in eye-care and OTC ophthalmic categories that are Rohto Mentholatum's flagship offerings.
  • Senju Pharmaceutical: Japanese ophthalmic pharmaceutical manufacturer with a strong OTC eye-drop portfolio. Highly comparable in formulation type, channel (pharmacy retail), and Asian market focus.
  • Kobayashi Pharmaceutical: Japanese OTC pharmaceutical and personal-care company. Comparable in business model of branded OTC healthcare products, including ophthalmics, skincare, and consumer health categories.
  • Lion Corporation: Japanese household and personal-care products manufacturer with OTC and pharmaceutical offerings. Comparable in combining consumer health, oral care, and topical pharmaceutical categories.
  • DHG Pharmaceutical: One of Vietnam's largest domestic pharmaceutical manufacturers. Directly comparable as a Vietnamese-headquartered pharma manufacturer competing for the same shelf space, pharmacy relationships, and consumer healthcare spend.
  • Traphaco: Major Vietnamese pharmaceutical company with a strong OTC and consumer healthcare portfolio. Comparable as a domestic competitor pursuing similar OTC pharmaceutical and health-cosmetic categories.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

Rohto Mentholatum social profiles

Digital presence

Rohto Mentholatum financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Rohto Mentholatum leadership team

Management profile

Number of profiles

Rohto Mentholatum funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Rohto Mentholatum M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rohto Mentholatum

What does Rohto Mentholatum do?

Rohto Mentholatum manufactures and sells pharmaceuticals and health-care cosmetic products. Operating in Vietnam under the Rohto corporate brand, the company produces consumer healthcare, personal care, and ophthalmic-related items distributed through retail pharmacy and modern trade channels.

Is Rohto Mentholatum a public or private company?

Rohto Mentholatum is a private company. It is classified as corporate owned and is currently operating.

When was Rohto Mentholatum founded?

Rohto Mentholatum was founded in 1996. It employs 11 to 50 people.

Where is Rohto Mentholatum based?

Rohto Mentholatum is headquartered in Hanoi, Vietnam, in the Asia region.

Who are Rohto Mentholatum's main competitors?

Broad incumbents on record are Rohto Pharmaceutical, Taisho Pharmaceutical, Daiichi Sankyo Healthcare and Bausch + Lomb. Direct peers are Santen Pharmaceutical, Senju Pharmaceutical, Kobayashi Pharmaceutical, Lion Corporation, DHG Pharmaceutical and Traphaco.

Does Rohto Mentholatum have an API?

No public API is recorded for Rohto Mentholatum.

What industry is Rohto Mentholatum in?

Rohto Mentholatum's product category is Consumer Healthcare and Personal Care Manufacturing. Its primary akta.pro industry code is HLAIADAF, Eye, Ear & Nasal Care, with a secondary code of HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Cool DownNearly 12 million eye drop bottles pulled nationwide after company says 'sterility cannot be assured'Rohto-Mentholatum (Vietnam) Co. Ltd. has issued a nationwide recall of approximately 12 million over-the-counter eye drop bottles after stating that sterility cannot be assured for the products. The FDA classified this action as a Class II recall, meaning use could cause temporary or medically reversible health problems, and the recall covers more than 180 combinations of products, lot numbers, and expiration dates across multiple Rohto varieties. Consumers who have purchased these eye drops should verify their bottle's lot number and expiration date against the recall listings and discontinue use if their product is affected.QuartzRohto eye drops recalled over sterility concernsRohto-Mentholatum initiated a voluntary recall of eight Cooling Eye Drop products on July 14, covering more than 12.4 million bottles distributed nationwide, due to a lack of sterility assurance that could expose users to germ contamination or infection. The FDA classified the recall as Class II, indicating the risk of serious harm is considered remote with any adverse effects expected to be temporary or reversible. The affected products, manufactured by Rohto-Mentholatum (Vietnam) Co., Ltd. and distributed in the US by The Mentholatum Company, carry expiration dates stretching from July 2026 to February 2029.YahooRohto eye drops recalled over sterility concernsRohto-Mentholatum initiated a voluntary recall of over 12 million bottles of Cooling Eye Drops on July 14, 2026, due to a "lack of assurance of sterility" that could expose users to germ contamination or infection. The recall covers eight products manufactured by Rohto-Mentholatum (Vietnam) Co., Ltd. and distributed nationwide in the United States by The Mentholatum Company, with expiration dates stretching from July 2026 to February 2029. The FDA classified this as a Class II recall, noting the risk of serious harm is considered remote with any adverse effects expected to be temporary or reversible.The Times of IndiaFDA recalls over 11 million Rohto eye drop cartons nationwide over sterility concernsRohto-Mentholatum (Vietnam) Co., Ltd. voluntarily initiated a nationwide recall of approximately 11,060,623 cartons of Rohto Cooling Eye Drops sold in the United States due to a lack of sterility assurance. The FDA classified the recall as Class II on July 23, 2026, meaning the products may cause temporary or medically reversible adverse health consequences, with the probability of serious harm considered remote. The recall covers eight product varieties including Rohto Cooling Eye Drops Max Strength (over 6 million cartons), Cool Relief (over 2.9 million cartons), and Optic Glow (over 1.2 million cartons), and remains ongoing as affected products are removed from distribution.